SCHEMBL5176339

SCHEMBL5176339

Cc1ccc(NC(=O)c2c(F)c(F)c(CN3CCN(C)CC3)c(F)c2F)cc1Nc1nc(-c2cccnc2)cs1.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Cc1nc(-c2cccnc2)cs1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 9/20 0.63
BCR P11274 6/20 0.63
LYN P07948 4/20 0.63
KIT P10721 10/20 0.62
CSF1R P07333 8/20 0.62
EGFR P00533 3/20 0.62
BRAF P15056 3/20 0.62
PDGFRB P09619 2/20 0.62
ERBB2 P04626 1/20 0.62
LCK P06239 1/20 0.62
FYN P06241 1/20 0.62
YES1 P07947 1/20 0.62
HCK P08631 1/20 0.62
FGR P09769 1/20 0.62
PIM1 P11309 1/20 0.62
SLC25A6 P12236 1/20 0.62
SRC P12931 1/20 0.62
NQO2 P16083 1/20 0.62
PDGFRA P16234 1/20 0.62
EPHA3 P29320 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4830586 0.89 KIT (0.77) ABL1BCRLYNKITCSF1R
SCHEMBL717868 0.89 KIT (0.69) ABL1BCRLYNKITCSF1R
SCHEMBL716232 0.86 ABL1 (0.75) ABL1BCRLYNKITCSF1R
SCHEMBL5133079 0.84 ABL1 (0.54) ABL1BCRLYNKITCSF1R
SCHEMBL3561586 0.83 KIT (0.71) ABL1BCRLYNKITCSF1R
SCHEMBL717080 0.82 ABL1 (0.80) ABL1BCRLYNKITCSF1R
Hydrochloric Acid SCHEMBL6014047 0.82 KIT (0.70) ABL1BCRLYNKITCSF1R
SCHEMBL14286281 0.82 ABL1 (0.84) ABL1BCRLYNKITCSF1R
SCHEMBL5133080 0.81 ABL1 (0.50) ABL1BCRLYNKITCSF1R
SCHEMBL5025223 0.81 BRAF (0.73) ABL1BCRLYNKITCSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742633-A2 USE OF C-KIT INHIBITORS FOR TREATING FIBROSIS AB Science (FR) 2007-01-17 EP disclosed
WO-2005115385-A1 USE OF C-KIT INHIBITORS FOR TREATING ACNE AB SCIENCE (FR) 2005-12-08 WO disclosed
WO-2005102346-A2 USE OF C-KIT INHIBITORS FOR TREATING FIBROSIS AB SCIENCE (FR) 2005-11-03 WO disclosed